Company Filing History:
Years Active: 2017-2020
Title: Olivier Frédéric Subiger: Innovator in Antibody Development
Introduction
Olivier Frédéric Subiger is a notable inventor based in Belleville sur Saône, France. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific cell types. With a total of 2 patents, his work has the potential to impact therapeutic strategies in cancer treatment.
Latest Patents
Subiger's latest patents include innovative approaches to anti-DR5 family antibodies. These patents describe bispecific or multivalent anti-DR5 family antibodies and methods of use thereof. The disclosed antibodies are designed to trigger cell death in DR5 positive cells, offering a promising avenue for targeted cancer therapies.
Career Highlights
Throughout his career, Olivier has worked with prominent companies in the biotechnology sector, including Genmab B.V. and Genmab Holding B.V. His experience in these organizations has allowed him to refine his expertise in antibody development and therapeutic applications.
Collaborations
Olivier has collaborated with esteemed colleagues such as Claudine Brigitte Fernande Vermot-Desroches and Laurence Françoise Jeanne-Marie Bourdin. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Olivier Frédéric Subiger stands out as an influential inventor in the field of antibody research, with a focus on innovative therapies for cancer treatment. His contributions through patents and collaborations highlight his commitment to advancing medical science.